Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial | Depressive Disorders | JAMA Psychiatry | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Kersting  A, Brähler  E, Glaesmer  H, Wagner  B.  Prevalence of complicated grief in a representative population-based sample.  J Affect Disord. 2011;131(1-3):339-343.PubMedGoogle ScholarCrossref
He  L, Tang  S, Yu  W, Xu  W, Xie  Q, Wang  J.  The prevalence, comorbidity and risks of prolonged grief disorder among bereaved Chinese adults.  Psychiatry Res. 2014;219(2):347-352.PubMedGoogle ScholarCrossref
Shear  MK.  Clinical practice. complicated grief.  N Engl J Med. 2015;372(2):153-160.PubMedGoogle ScholarCrossref
Cozza  SJ, Fisher  JE, Mauro  CM,  et al.  Performance of DSM-5 Persistent Complex Bereavement Disorder criteria in a community sample of bereaved military family members.  Am J Psychiatry. In Press.Google Scholar
Shear  K, Frank  E, Houck  PR, Reynolds  CF  III.  Treatment of complicated grief: a randomized controlled trial.  JAMA. 2005;293(21):2601-2608.PubMedGoogle ScholarCrossref
Shear  MK, Wang  Y, Skritskaya  N, Duan  N, Mauro  C, Ghesquiere  A.  Treatment of complicated grief in elderly persons: a randomized clinical trial.  JAMA Psychiatry. 2014;71(11):1287-1295.PubMedGoogle ScholarCrossref
American Psychiatric Association.  Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
Prigerson  HG, Maciejewski  PK, Reynolds  CF  III,  et al.  Inventory of Complicated Grief: a scale to measure maladaptive symptoms of loss.  Psychiatry Res. 1995;59(1-2):65-79.PubMedGoogle ScholarCrossref
Bui  E, Mauro  C, Robinaugh  DJ,  et al.  The structured clinical interview for complicated grief: reliability, validity, and exploratory factor analysis.  Depress Anxiety. 2015;32(7):485-492.PubMedGoogle ScholarCrossref
Zisook  S, Shuchter  SR, Pedrelli  P, Sable  J, Deaciuc  SC.  Bupropion sustained release for bereavement: results of an open trial.  J Clin Psychiatry. 2001;62(4):227-230.PubMedGoogle ScholarCrossref
Simon  NM, Shear  MK, Fagiolini  A,  et al.  Impact of concurrent naturalistic pharmacotherapy on psychotherapy of complicated grief.  Psychiatry Res. 2008;159(1-2):31-36.PubMedGoogle ScholarCrossref
Hensley  PL, Slonimski  CK, Uhlenhuth  EH, Clayton  PJ.  Escitalopram: an open-label study of bereavement-related depression and grief.  J Affect Disord. 2009;113(1-2):142-149.PubMedGoogle ScholarCrossref
Simon  NM.  Treating complicated grief.  JAMA. 2013;310(4):416-423.PubMedGoogle ScholarCrossref
Guy  W. Clinical Global Impressions. In: Guy  W, ed.  ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Department of Health, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration; 1976:218-222.
First  MB  Sr, Spitzer  RL, Gibbon  M, Williams  JBW.  Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002.
Posner  K, Brown  GK, Stanley  B,  et al.  The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.  Am J Psychiatry. 2011;168(12):1266-1277.PubMedGoogle ScholarCrossref
Hafner  J, Marks  I.  Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation.  Psychol Med. 1976;6(1):71-88.PubMedGoogle ScholarCrossref
Mundt  JC, Marks  IM, Shear  MK, Greist  JH.  The Work and Social Adjustment Scale: a simple measure of impairment in functioning.  Br J Psychiatry. 2002;180:461-464.PubMedGoogle ScholarCrossref
Shear  K, Monk  T, Houck  P,  et al.  An attachment-based model of complicated grief including the role of avoidance.  Eur Arch Psychiatry Clin Neurosci. 2007;257(8):453-461.PubMedGoogle ScholarCrossref
Rush  AJ, Trivedi  MH, Ibrahim  HM,  et al.  The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.  Biol Psychiatry. 2003;54(5):573-583.PubMedGoogle ScholarCrossref
Brick  JM, Kalton  G.  Handling missing data in survey research.  Stat Methods Med Res. 1996;5(3):215-238.PubMedGoogle ScholarCrossref
National Research Council of the National Academies.  The Prevention and Treatment of Missing Data in Clinical Trials. Washington, DC: National Academies Press; 2010.
Seaman  SR, White  IR.  Review of inverse probability weighting for dealing with missing data.  Stat Methods Med Res. 2013;22(3):278-295.PubMedGoogle ScholarCrossref
Little  RJ, D’Agostino  R, Cohen  ML,  et al.  The prevention and treatment of missing data in clinical trials.  N Engl J Med. 2012;367(14):1355-1360.PubMedGoogle ScholarCrossref
SAS Institute Inc.  Base SAS 9.3 Procedures Guide: Statistical Procedures. Cary, North Carolina: SAS Institute Inc; 2011.
Szanto  K, Prigerson  H, Houck  P, Ehrenpreis  L, Reynolds  CF  III.  Suicidal ideation in elderly bereaved: the role of complicated grief.  Suicide Life Threat Behav. 1997;27(2):194-207.PubMedGoogle Scholar
Latham  AE, Prigerson  HG.  Suicidality and bereavement: complicated grief as psychiatric disorder presenting greatest risk for suicidality.  Suicide Life Threat Behav. 2004;34(4):350-362.PubMedGoogle ScholarCrossref
Szanto  K, Shear  MK, Houck  PR,  et al.  Indirect self-destructive behavior and overt suicidality in patients with complicated grief.  J Clin Psychiatry. 2006;67(2):233-239.PubMedGoogle ScholarCrossref
Rosner  R, Pfoh  G, Kotoučová  M.  Treatment of complicated grief [published online November 14, 2011].  Eur J Psychotraumatol.PubMedGoogle Scholar
Shear  MK, Frank  E, Foa  E,  et al.  Traumatic grief treatment: a pilot study.  Am J Psychiatry. 2001;158(9):1506-1508.PubMedGoogle ScholarCrossref
Kersting  A, Dölemeyer  R, Steinig  J,  et al.  Brief internet-based intervention reduces posttraumatic stress and prolonged grief in parents after the loss of a child during pregnancy: a randomized controlled trial.  Psychother Psychosom. 2013;82(6):372-381.PubMedGoogle ScholarCrossref
Litz  BT, Schorr  Y, Delaney  E,  et al.  A randomized controlled trial of an internet-based therapist-assisted indicated preventive intervention for prolonged grief disorder.  Behav Res Ther. 2014;61:23-34.PubMedGoogle ScholarCrossref
Wagner  B, Knaevelsrud  C, Maercker  A.  Internet-based cognitive-behavioral therapy for complicated grief: a randomized controlled trial.  Death Stud. 2006;30(5):429-453.PubMedGoogle ScholarCrossref
Papa  A, Sewell  MT, Garrison-Diehn  C, Rummel  C.  A randomized open trial assessing the feasibility of behavioral activation for pathological grief responding.  Behav Ther. 2013;44(4):639-650.PubMedGoogle ScholarCrossref
Trivedi  MH, Rush  AJ, Wisniewski  SR,  et al; STAR*D Study Team.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.  Am J Psychiatry. 2006;163(1):28-40.PubMedGoogle ScholarCrossref
Zisook  S, Shear  K.  Grief and bereavement: what psychiatrists need to know.  World Psychiatry. 2009;8(2):67-74.PubMedGoogle ScholarCrossref
Shear  MK.  Getting straight about grief.  Depress Anxiety. 2012;29(6):461-464.PubMedGoogle ScholarCrossref
Original Investigation
July 2016

Optimizing Treatment of Complicated Grief: A Randomized Clinical Trial

Author Affiliations
  • 1Columbia School of Social Work, Columbia University College of Physicians and Surgeons, New York, New York
  • 2Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York
  • 3Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
  • 4Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston
  • 5Harvard Medical School, Boston, Massachusetts
  • 6Department of Psychiatry, University of California, San Diego
  • 7Veterans Affairs San Diego Healthcare System, La Jolla, California
  • 8Veterans Medical and Research Foundation, La Jolla, California
  • 9Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, New York
  • 10Division of Biostatistics, Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York
JAMA Psychiatry. 2016;73(7):685-694. doi:10.1001/jamapsychiatry.2016.0892

Importance  To our knowledge, this is the first placebo-controlled randomized clinical trial to evaluate the efficacy of antidepressant pharmacotherapy, with and without complicated grief psychotherapy, in the treatment of complicated grief.

Objective  To confirm the efficacy of a targeted complicated grief treatment (CGT), determine whether citalopram (CIT) enhances CGT outcome, and examine CIT efficacy without CGT.

Design, Setting, and Participants  Included in the study were 395 bereaved adults who met criteria for CG recruited from March 2010 to September 2014 from academic medical centers in Boston, Massachusetts; New York, New York; Pittsburgh, Pennsylvania; and San Diego, California. Co-occurring substance abuse, psychosis, mania, and cognitive impairment were exclusionary. Study participants were randomized using site-specific permuted blocks stratified by major depression into groups prescribed CIT (n = 101), placebo (PLA; n = 99), CGT with CIT (n = 99), and CGT with PLA (n = 96). Independent evaluators conducted monthly assessments for 20 weeks. Response rates were compared under the intention-to-treat principle, including all randomized participants in a logistic regression with inverse probability weighting.

Interventions  All participants received protocolized pharmacotherapy optimized by flexible dosing, psychoeducation, grief monitoring, and encouragement to engage in activities. Half were also randomized to receive manualized CGT in 16 concurrent weekly sessions.

Main Outcomes and Measures  Complicated grief–anchored Clinical Global Impression scale measurments every 4 weeks. Response was measured as a rating of “much improved” or “very much improved.”

Results  Of the 395 study participants, 308 (78.0%) were female and 325 (82.3%) were white. Participants’ response to CGT with PLA vs PLA (82.5% vs 54.8%; relative risk [RR], 1.51; 95% CI, 1.16-1.95; P = .002; number needed to treat [NNT], 3.6) suggested the efficacy of CGT, and the addition of CIT did not significantly improve CGT outcome (CGT with CIT vs CGT with PLA: 83.7% vs 82.5%; RR, 1.01; 95% CI, 0.88-1.17; P = .84; NNT, 84). However, depressive symptoms decreased significantly more when CIT was added to treatment (CGT with CIT vs CGT with PLA: model-based adjusted mean [standard error] difference, −2.06 [1.00]; 95% CI, −4.02 to −0.11; P = .04). By contrast, adding CGT improved CIT outcome (CIT vs CGT with CIT: 69.3% vs 83.7%; RR, 1.21; 95% CI, 1.00-1.46; P = .05; NNT, 6.9). Last, participant response to CIT was not significantly different from PLA at week 12 (45.9% vs 37.9%; RR, 1.21; 95% CI, 0.82-1.81; P = .35; NNT, 12.4) or at week 20 (69.3% vs 54.8%; RR, 1.26; 95% CI, 0.95-1.68; P = .11; NNT, 6.9). Rates of suicidal ideation diminished to a substantially greater extent among participants receiving CGT than among those who did not.

Conclusions and Relevance  Complicated grief treatment is the treatment of choice for CG, and the addition of CIT optimizes the treatment of co-occurring depressive symptoms.

Trial Registration  clinicaltrials.gov Identifier: NCT01179568